Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-12-27 | Sarepta Therapeutics, Inc. | Estepan Ian Michael
(Chief Financial Officer) |
G | Common Stock | D | 250 | $0.00 - $0.00 | $0 |
| 2024-12-12 | Sarepta Therapeutics, Inc. | Wigzell Hans Lenn...
(Director) |
S | Common Stock | D | 10500 | $124.84 - $124.84 | $1,310,820 |
| 2024-12-12 | Sarepta Therapeutics, Inc. | Wigzell Hans Lenn...
(Director) |
M | Common Stock | A | 10500 | $13.71 - $13.71 | $143,955 |
| 2024-12-05 | Sarepta Therapeutics, Inc. | Boor Kathryn Jean
(Director) |
S | Common Stock | D | 1636 | $125.55 - $125.55 | $205,399 |
| 2024-11-26 | Sarepta Therapeutics, Inc. | Rothfuss Cristin
(EVP, General Counsel) |
A | Common Stock | A | 2000 | $0.00 - $0.00 | $0 |
| 2024-11-18 | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise
(Head of R&D, CSO) |
F | Common Stock | D | 4558 | $102.89 - $102.89 | $468,972 |
| 2024-09-12 | Sarepta Therapeutics, Inc. | Connelly Deirdre P
(Director) |
A | Common Stock | A | 2842 | $0.00 - $0.00 | $0 |
| 2024-08-16 | Sarepta Therapeutics, Inc. | Chambers Michael ...
(Director) |
P | Common Stock | A | 37038 | $133.07 - $134.66 | $4,955,727 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |